Back

Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence. A report from the NOMED-AF prospective cross-sectional observational study

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Impact of comorbidities on cardiovascular outcome in patients with atrial fibrillation Prevalence and Incidence of Atrial Fibrillation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Jakub Gumprecht

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

6 More presentations in this session

Presentation thumbnail
External validation of the new REACT-HF score for heart failure prediction in patients with atrial fibrillation
Doctor G. Moschovitis (Lugano, CH)
Abstract Slides Video
Presentation thumbnail
Influence of heart failure and chronic kidney disease on cardiovascular outcome in patients with atrial fibrillation - insights from a cohort study of 7,412 patients
Doctor U. Baumer (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Incidence and predictors of the novo significant mitral and tricuspid regurgitation in patients with permanent atrial fibrillation
Ms A. Lizancos Castro (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Prognostic value of monocyte-to-high-density lipoprotein-cholesterol ratio for all-cause mortality and heart failure in new-onset atrial fibrillation: a population-based cohort study
Mr C. Tsang (Hong Kong, HK)
Abstract Slides Video
Presentation thumbnail
Temporal association between atrial fibrillation burden in cardiac implantable electronic devices and the risk of heart failure hospitalization
Mr S. Majumder (Minneapolis, US)
Abstract Slides Video

Access the full session

Session thumbnail
Impact of comorbidities on cardiovascular outcome in patients with atrial fibrillation

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources